Uscom boosts global sales and marketing
New global Sales and Marketing Manager appointed to support release of new products
Left to Right: Denise Pater, Damien Linnett and Rob Phillips
Uscom today announced the appointment of Damien Linnett to the position of Global Sales and Marketing Manager. Mr Linnett is an economics graduate from the University of Queensland, with an MBA in international marketing. He has over 20 years’ global medical device sales and marketing management experience.
Damien Linnett has previously held executive positions with international corporations Datex-Ohmeda and Spacelabs Healthcare, and most recently with Kinetic Concepts Inc. (KCI Medical), an Acelity Company. Mr Linnett joins the growing sales, marketing and distribution division of Uscom to accommodate and advance the increased product suites of Uscom devices.
Uscom has completed the development of the new BP+ and SpiroSonic devices and now has them in regulatory cycles, awaiting multiple jurisdiction approvals in China (CFDA), Europe (CE) and USA (FDA). The focus of the sales, marketing and distribution division will be to sign up new specialist distributors, manage the sale of the new devices, and grow the new revenue streams.
Mr Linnett said, “Uscom is a business in transformation as it approaches profitability with 7 new standard of care products due for imminent release to market. For me that represents an opportunity to accelerate global sales and revenue growth. Uscom has a growing international reputation as a corporation and manufacturer of premium medical devices with a great foundation product and rapidly growing market share. I’m looking forward to being a part of the Uscom growth story, and adding my skills to those of the current team to accelerate sales as we bring these new and exciting products to market.”
Uscom CEO Associate Professor Rob Phillips said, “Uscom sales have grown by over 60% CAGR over the last 3 years, we have acquired 2 companies, and are poised for the imminent release of 7 new products into the Chinese, European and US markets. We currently manage approximately 35 distributors globally and this number will grow, with 10 new distributors signed up and awaiting the release of the BP+ devices. Having someone of Damien’s outstanding capabilities and experience join our team to guide our new products into the market is ideal. Our continued growth requires experienced management and a strong and capable sales, marketing and distribution strategy, and Damien’s contribution to our global sales, marketing and distribution division will be central to Uscom’s future commercial success.”
Uscom manufactures and markets the USCOM 1A, the Uscom BP+, and the Uscom SpiroSonic digital ultrasonic spirometry technologies. These premium digital devices are changing the way we diagnose and treat cardiovascular and pulmonary diseases, including hypertension, heart failure, asthma, COPD and sleep disorders. The devices and technologies are integral for optimising management of sepsis and guidance of fluid, inotropes and vasoactive therapies in critical care monitoring, and in clinical and home care delivered asthma and COPD diagnosis and medication monitoring.